亚洲无线乱码高清在线观看一区,色一级,精品伊人久久,2018国产大陆天天弄,狠狠操夜夜爱,欧美日韩中文字幕在线,日本人视频网站一

首頁(yè) /藥靶模型 /藥靶細(xì)胞 /激酶靶點(diǎn) /TEL-KDR/BaF3

TEL-KDR/BaF3

CBP73305

詢 價(jià)
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
I. Introduction

Cell Line Name:

TEL-KDR/BaF3

Host Cell:

Ba/F3

Stability: 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

 
II. Background

KDR (VEGFR2), kinase insert domain receptor, is also known as vascular endothelial growth factor receptor 2 and is an endothelial cell surface receptor tyrosine kinase and member of the vascular endothelial growth factor family of proteins that plays a role in angiogenesis and cell proliferation through activation of RAF-MEK-MAP and PI3K-AKT pathways (PMID: 25568876, PMID: 29093528, PMID: 26578684). KDR amplification and overexpression have been reported in a variety of tumor types (PMID: 21382095, PMID: 27218826, PMID: 25231439, PMID: 20606037, PMID: 30819137) and somatic mutations have been reported in sarcomas and head and neck squamous cell carcinomas (PMID: 22314185, PMID: 11801954).

 
III. Representative Data

1.Sanger of TEL-KDR/BaF3

2. Anti-proliferation assay  

Figure 2. CTG Proliferation Assay of BaF3 TEL-KDR Cells (C12).

 
 

藥靶模型聯(lián)系方式: 華東銷(xiāo)售經(jīng)理:18240630236 全國(guó)銷(xiāo)售經(jīng)理:18066071954
診斷標(biāo)準(zhǔn)品聯(lián)系方式: 華東銷(xiāo)售經(jīng)理:15000320447 華北銷(xiāo)售經(jīng)理:18131625521 華南銷(xiāo)售經(jīng)理:13484295986 華中&西南銷(xiāo)售經(jīng)理:13871580511 全國(guó)銷(xiāo)售經(jīng)理:13484295986

掃二維碼

立即提交
忻城县| 巴林左旗| 梁河县| 法库县| 永修县| 张家界市| 东海县| 饶河县| 周宁县| 安义县| 莱芜市| 石楼县| 伊川县| 盐边县| 灌南县| 博兴县| 托克逊县| 东平县| 收藏| 泰兴市| 正镶白旗| 建水县| 万山特区| 丹凤县| 泸西县| 涿州市| 石城县| 尖扎县| 保康县| 武乡县| 毕节市| 武清区| 江华| 十堰市| 乌审旗| 定襄县| 保靖县| 三台县| 南投县| 长汀县| 黄大仙区|